계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
EvolveImmune Therapeutics
company
About
EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $17.54M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generate first-in-class treatments for unmet needs in oncology and autoimmune diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17.54M
EvolveImmune Therapeutics has raised a total of
$17.54M
in funding over 2 rounds. Their latest funding was raised on
Jan 8, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 8, 2020 | Series Unknown | $17.54M | 1 |
Pfizer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
EvolveImmune Therapeutics is funded by 1 investors.
Pfizer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pfizer
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
